作者
- Antman, E.M. (33)
- Braunwald, E. (39)
- Cannon, C.P. (11)
- Gibson, C.M. (18)
- Giugliano, R.P. (12)
- McCabe, C.H. (27)
- Morrow, D.A. (57)
- Murphy, S.A. (18)
- Sabatine, M.S. (21)
- de Lemos, J.A. (19)
|
總筆數:57
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Very early risk stratification after thrombolytic therapy with a bedsidemyoglobin assay and the 12-lead electrocardiogram |
de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.;for the InTIME-II investigators; |
American Heart Journal |
2000-09-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with a bedsidemyoglobin assay and the 12-lead electrocardiogram |
de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.;for the InTIME-II investigators; |
American Heart Journal |
2000-09-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with abedside myoglobin assay and the 12-lead electrocardiogram |
for the InTIME-II investigators;de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.; |
American Heart Journal |
2000-09-01 |
查看 |
| Abciximab and early adjunctive percutaneous coronary intervention areassociated with improved ST-segment resolution after thrombolysis:Observations from the TIMI 14 Trial |
de Lemos, J.A.;Gibson, C.M.;Antman, E.M.;Murphy, S.A.;Morrow, D.A.;Schuhwerk, K.C.;Schweiger, M.;Coussement, P.;Van de Werf, F.;Braunwald, E.;for the TIMI 14 Investigators; |
American Heart Journal |
2001-04-01 |
查看 |
| Abciximab and early adjunctive percutaneous coronary intervention areassociated with improved ST-segment resolution after thrombolysis:Observations from the TIMI 14 Trial |
de Lemos, J.A.;Gibson, C.M.;Antman, E.M.;Murphy, S.A.;Morrow, D.A.;Schuhwerk, K.C.;Schweiger, M.;Coussement, P.;Van de Werf, F.;Braunwald, E.;for the TIMI 14 Investigators; |
American Heart Journal |
2001-04-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method foridentifying patients with a patent infarction-related artery afterfibrinolytic administration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Assessing the success of fibrinolysis: Can we let the interventionalistrest? |
Morrow, D.A.;de Lemos, J.A.; |
American Heart Journal |
2003-03-01 |
查看 |
| Noninvasive assessment of reperfusion therapy: slow progress towards aworthwhile goal |
de Lemos, J.A.;Morrow, D.A.; |
American Heart Journal |
2003-11-01 |
查看 |
| New insight into clinical risk scores for patients with acute coronarysyndromes |
Morrow, D.A.; |
American Heart Journal |
2003-11-01 |
查看 |
| Validated risk score predicts the development of congestive heart failureafter presentation with unstable angina or non-ST-elevation myocardialinfarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 |
Wylie, J.V.;Murphy, S.A.;Morrow, D.A.;de Lemos, J.A.;Antman, E.M.;Cannon, C.P.; |
American Heart Journal |
2004-07-01 |
查看 |
| Validated risk score predicts the development of congestive heart failureafter presentation with unstable angina or non-ST-elevation myocardialinfarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 |
Wylie, J.V.;Murphy, S.A.;Morrow, D.A.;de Lemos, J.A.;Antman, E.M.;Cannon, C.P.; |
American Heart Journal |
2004-07-01 |
查看 |
| Validated risk score predicts the development of congestive heart failureafter presentation with unstable angina or non-ST-elevation myocardialinfarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 |
Wylie, J.V.;Murphy, S.A.;Morrow, D.A.;de Lemos, J.A.;Antman, E.M.;Cannon, C.P.; |
American Heart Journal |
2004-07-01 |
查看 |
| Angiographic perfusion score: An angiographic variable that integrates bothepicardial and tissue level perfusion before and after facilitatedpercutaneous coronary intervention in acute myocardial infarction |
Gibson, C.M.;Murphy, S.A.;Morrow, D.A.;Aroesty, J.M.;Gibbons, R.J.;Gourlay, S.G.;Barron, H.V.;Giugliano, R.P.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2004-08-01 |
查看 |
| Angiographic perfusion score: An angiographic variable that integrates bothepicardial and tissue level perfusion before and after facilitatedpercutaneous coronary intervention in acute myocardial infarction |
Gibson, C.M.;Murphy, S.A.;Morrow, D.A.;Aroesty, J.M.;Gibbons, R.J.;Gourlay, S.G.;Barron, H.V.;Giugliano, R.P.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2004-08-01 |
查看 |
| Evidence-based decision limits for cardiac troponin: Low-level elevationand prognosis |
Morrow, D.A.; |
American Heart Journal |
2004-11-01 |
查看 |
| Evidence-based decision limits for cardiac troponin: Low-level elevationand prognosis |
Morrow, D.A.; |
American Heart Journal |
2004-11-01 |
查看 |
| Evidence-based decision limits for cardiac troponin: Low-levelelevation and prognosis |
Morrow, D.A.; |
American Heart Journal |
2004-11-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction -Design and rationale for the Enoxaparin and Thrombolysis Reperfusion forAcute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarctionstudy 25 (ExTRACT-TIMI 25) |
Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.;for the ExTRACT-TIMI 25 Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction -Design and rationale for the Enoxaparin and Thrombolysis Reperfusion forAcute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarctionstudy 25 (ExTRACT-TIMI 25) |
Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.;for the ExTRACT-TIMI 25 Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction -Design and rationale for the Enoxaparin and Thrombolysis Reperfusion forAcute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarctionstudy 25 (ExTRACT-TIMI 25) |
Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.;for the ExTRACT-TIMI 25 Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction |
for the ExTRACT-TIMI 25 Investigators;Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.; |
American Heart Journal |
2005-02-01 |
查看 |
| Correlation between the TIMI risk score and high-risk angiographic findingsin non-ST-elevation acute coronary syndromes: Observations from thePlatelet Receptor Inhibition in Ischemic Syndrome Management in PatientsLimited by Unstable Signs and Symptoms (PRISM-PLUS) trial |
Mega, J.L.;Morrow, D.A.;Sabatine, M.S.;Zhao, X.-Q.;Snapinn, S.M.;DiBattiste, P.M.;Gibson, C.M.;Antman, E.M.;Braunwald, E.;Theroux, P.; |
American Heart Journal |
2005-05-01 |
查看 |
| Correlation between the TIMI risk score and high-risk angiographicfindings in non-ST-elevation acute coronary syndromes: Observations fromthe Platelet Receptor Inhibition in Ischemic Syndrome Management inPatients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial |
Mega, J.L.;Morrow, D.A.;Sabatine, M.S.;Zhao, X.Q.;Snapinn, S.M.;DiBattiste, P.M.;Gibson, C.M.;Antman, E.M.;Braunwald, E.;Theroux, P.; |
American Heart Journal |
2005-05-01 |
查看 |
| Correlation between the TIMI risk score and high-risk angiographicfindings in non-ST-elevation acute coronary syndromes: Observations fromthe Platelet Receptor Inhibition in Ischemic Syndrome Management inPatients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial |
Mega, J.L.;Morrow, D.A.;Sabatine, M.S.;Zhao, X.Q.;Snapinn, S.M.;DiBattiste, P.M.;Gibson, C.M.;Antman, E.M.;Braunwald, E.;Theroux, P.; |
American Heart Journal |
2005-05-01 |
查看 |
| Combination of quantitative ST deviation and troponin elevationprovides independent prognostic and therapeutic information in unstableangina and non-ST-elevation myocardial infarction |
Sabatine, M.S.;Morrow, D.A.;McCabe, C.H.;Antman, E.M.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2006-01-01 |
查看 |
| Combination of quantitative ST deviation and troponin elevationprovides independent prognostic and therapeutic information in unstableangina and non-ST-elevation myocardial infarction |
Sabatine, M.S.;Morrow, D.A.;McCabe, C.H.;Antman, E.M.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2006-01-01 |
查看 |
| Predicting a late positive serum troponin in initiallytroponin-negative patients with non-ST-elevation acute coronary syndrome:Clinical predictors and validated risk score results from the TIMI IIIB andGUSTO IIA studies |
Januzzi, J.L.;Newby, L.K.;Murphy, S.A.;Pieper, K.;Antman, E.M.;Morrow, D.A.;Sabatine, M.S.;Ohman, E.M.;Cannon, C.P.;Braunwald, E.; |
American Heart Journal |
2006-02-01 |
查看 |
| Evaluation of a novel anti-ischemic agent in acute coronary syndromes:Design and rationale for the Metabolic Efficiency with Ranolazine for LessIschemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial |
for the MERLIN-TIMI 36 Investigators;Morrow, D.A.;Scirica, B.M.;Karwatowska-Prokopczuk, E.;Skene, A.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-06-01 |
查看 |
| Evaluation of a novel anti-ischemic agent in acute coronary syndromes:Design and rationale for the Metabolic Efficiency with Ranolazine for LessIschemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial |
for the MERLIN-TIMI 36 Investigators;Morrow, D.A.;Scirica, B.M.;Karwatowska-Prokopczuk, E.;Skene, A.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-06-01 |
查看 |
| Evaluation of a novel anti-ischemic agent in acute coronary syndromes:Design and rationale for the Metabolic Efficiency with Ranolazine for LessIschemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial |
for the MERLIN-TIMI 36 Investigators;Morrow, D.A.;Scirica, B.M.;Karwatowska-Prokopczuk, E.;Skene, A.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-08-01 |
查看 |
| Evaluation of a novel anti-ischemic agent in acute coronary syndromes:Design and rationale for the Metabolic Efficiency with Ranolazine for LessIschemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial |
for the MERLIN-TIMI 36 Investigators;Morrow, D.A.;Scirica, B.M.;Karwatowska-Prokopczuk, E.;Skene, A.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-08-01 |
查看 |
| Association between Thrombolysis In Myocardial Infarction myocardialperfusion grade, biomarkers, and clinical outcomes among patients withmoderate- to high-risk acute coronary syndromes: Observations from theRandomized Trial to Evaluate the Relative PROTECTion against Post-PCIMicrovascular Dysfunction and Post-PCI Ischemia among Antiplatelet andAntithrombotic Agents-Thrombolysis In Myocardial Infarction 30(PROTECT-TIMI 30) |
for the TIMI Study Group;Gibson, C.M.;Kirtane, A.J.;Morrow, D.A.;Palabrica, T.M.;Murphy, S.A.;Stone, P.H.;Scirica, B.M.;Jennings, L.K.;Herrmann, H.C.;Cohen, D.J.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-10-01 |
查看 |
| Association between Thrombolysis In Myocardial Infarction myocardialperfusion grade, biomarkers, and clinical outcomes among patients withmoderate- to high-risk acute coronary syndromes: Observations from theRandomized Trial to Evaluate the Relative PROTECTion against Post-PCIMicrovascular Dysfunction and Post-PCI Ischemia among Antiplatelet andAntithrombotic Agents-Thrombolysis In Myocardial Infarction 30(PROTECT-TIMI 30) |
for the TIMI Study Group;Gibson, C.M.;Kirtane, A.J.;Morrow, D.A.;Palabrica, T.M.;Murphy, S.A.;Stone, P.H.;Scirica, B.M.;Jennings, L.K.;Herrmann, H.C.;Cohen, D.J.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-10-01 |
查看 |
| Use of natriuretic peptides in clinical decision-making for patientswith non-ST-elevation acute coronary syndromes |
de Lemos, J.A.;Morrow, D.A.; |
American Heart Journal |
2007-04-01 |
查看 |
| Global outcomes of ST-elevation myocardial infarction: Comparisons ofthe Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial InfarctionTreatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)registry and trial |
Steinberg, B.A.;Moghbeli, N.;Buros, J.;Ruda, M.;Parkhomenko, A.;Raju, B.S.;Garcia-Castillo, A.;Janion, M.;Nicolau, J.C.;Fox, K.A.A.;Morrow, D.A.;Gibson, C.M.;Antman, E.M.; |
American Heart Journal |
2007-07-01 |
查看 |
| Global outcomes of ST-elevation myocardial infarction: Comparisons ofthe Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial InfarctionTreatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)registry and trial |
Steinberg, B.A.;Moghbeli, N.;Buros, J.;Ruda, M.;Parkhomenko, A.;Raju, B.S.;Garcia-Castillo, A.;Janion, M.;Nicolau, J.C.;Fox, K.A.A.;Morrow, D.A.;Gibson, C.M.;Antman, E.M.; |
American Heart Journal |
2007-07-01 |
查看 |
| Effect of enoxaparin versus unfractionated heparin in diabetic patientswith ST-elevation myocardial infarction in the Enoxaparin and ThrombolysisReperfusion for Acute Myocardial Infarction Treatment-Thrombolysis InMyocardial Infarction study 25 (ExTRACT-TIMI 25) trial |
from the TIMI Study Group;Morrow, D.A.;Antman, E.M.;Murphy, S.A.;Qin, J.;Ruda, M.;Guneri, S.;Jacob, A.J.;Budaj, A.;Braunwald, E.; |
American Heart Journal |
2007-12-01 |
查看 |
| Effect of enoxaparin versus unfractionated heparin in diabetic patientswith ST-elevation myocardial infarction in the Enoxaparin and ThrombolysisReperfusion for Acute Myocardial Infarction Treatment-Thrombolysis InMyocardial Infarction study 25 (ExTRACT-TIMI 25) trial |
from the TIMI Study Group;Morrow, D.A.;Antman, E.M.;Murphy, S.A.;Qin, J.;Ruda, M.;Guneri, S.;Jacob, A.J.;Budaj, A.;Braunwald, E.; |
American Heart Journal |
2007-12-01 |
查看 |
| Myeloid-related protein 8/14 and the risk of cardiovascular death ormyocardial infarction after an acute coronary syndrome in the Pravastatinor Atorvastatin Evaluation and Infection Theraphy: Thrombolysis inMyocardial Infarction (PROVE IT-TIMI 22) trial |
Morrow, D.A.;Wang, Y.;Croce, K.;Sakuma, M.;Sabatine, M.S.;Gao, H.;Pradhan, A.D.;Healy, A.M.;Buros, J.;McCabe, C.H.;Libby, P.;Cannon, C.P.;Braunwald, E.;Simon, D.I.; |
American Heart Journal |
2008-01-01 |
查看 |
| Myeloid-related protein 8/14 and the risk of cardiovascular death ormyocardial infarction after an acute coronary syndrome in the Pravastatinor Atorvastatin Evaluation and Infection Theraphy: Thrombolysis inMyocardial Infarction (PROVE IT-TIMI 22) trial |
Morrow, D.A.;Wang, Y.;Croce, K.;Sakuma, M.;Sabatine, M.S.;Gao, H.;Pradhan, A.D.;Healy, A.M.;Buros, J.;McCabe, C.H.;Libby, P.;Cannon, C.P.;Braunwald, E.;Simon, D.I.; |
American Heart Journal |
2008-01-01 |
查看 |
| Evaluation of a novel antiplatelet agent for secondary prevention inpatients with a history of atherosclerotic disease: Design and rationalefor the Thrombin-Receptor Antagonist in Secondary Prevention ofAtherothrombotic Ischemic Events (TRA 2^oP)-TIMI 50 trial |
for the TRA 2^oP-TIMI 50 Investigators;Morrow, D.A.;Scirica, B.M.;Fox, K.A.A.;Berman, G.;Strony, J.;Veltri, E.;Bonaca, M.P.;Fish, P.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2009-09-01 |
查看 |
| Detection of myocardial injury in patients with unstable angina using anovel nanoparticle cardiac troponin I assay: Observations from thePROTECT-TIMI 30 Trial |
Wilson, S.R.;Sabatine, M.S.;Braunwald, E.;Sloan, S.;Murphy, S.A.;Morrow, D.A.; |
American Heart Journal |
2009-09-01 |
查看 |
| Evaluation of a novel antiplatelet agent for secondary prevention inpatients with a history of atherosclerotic disease: Design and rationalefor the Thrombin-Receptor Antagonist in Secondary Prevention ofAtherothrombotic Ischemic Events (TRA 2^oP)-TIMI 50 trial |
for the TRA 2^oP-TIMI 50 Investigators;Morrow, D.A.;Scirica, B.M.;Fox, K.A.A.;Berman, G.;Strony, J.;Veltri, E.;Bonaca, M.P.;Fish, P.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2009-09-01 |
查看 |
| Detection of myocardial injury in patients with unstable angina using anovel nanoparticle cardiac troponin I assay: Observations from thePROTECT-TIMI 30 Trial |
Wilson, S.R.;Sabatine, M.S.;Braunwald, E.;Sloan, S.;Murphy, S.A.;Morrow, D.A.; |
American Heart Journal |
2009-09-01 |
查看 |
| Extent of ST-segment resolution after fibrinolysis adds improved riskstratification to clinical risk score for ST-segment elevation myocardialinfarction |
Harkness, J.R.;Sabatine, M.S.;Braunwald, E.;Morrow, D.A.;Sloan, S.;Wiviott, S.D.;Giugliano, R.P.;Antman, E.M.;Cannon, C.P.;Scirica, B.M.; |
American Heart Journal |
2010-01-01 |
查看 |
|
|
|
